Meghan V. Joyce insider trades: Guardant Health (GH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Meghan reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | GH | ↓ Sell | 10,000 | $126.98 | $1.3M | Direct | Jun 4, 2026 (1d) |
| Sep 2, 2025 | GH | ↓ Sell | 100 | $65.84 | $7K | Direct | Sep 3, 2025 (1d) |
| Jun 13, 2025 | GH | ↓ Sell | 3,337 | $47.22 | $158K | Direct | Jun 16, 2025 (3d) |
| Jun 2, 2025 | GH | ↓ Sell | 100 | $41.66 | $4K | Direct | Jun 3, 2025 (1d) |
| Mar 3, 2025 | GH | ↓ Sell | 100 | $42.71 | $4K | Direct | Mar 5, 2025 (2d) |
| Dec 2, 2024 | GH | ↓ Sell | 100 | $35.90 | $4K | Direct | Dec 3, 2024 (1d) |
| Nov 13, 2024 | GH | ↓ Sell | 2,896 | $29.90 | $87K | Direct | Nov 14, 2024 (1d) |
| Jun 4, 2024 | GH | ↓ Sell10b5-1 | 100 | $27.87 | $3K | Direct | Jun 5, 2024 (1d) |
| Mar 4, 2024 | GH | ↓ Sell10b5-1 | 100 | $19.05 | $2K | Direct | Mar 5, 2024 (1d) |
| Dec 4, 2023 | GH | ↓ Sell10b5-1 | 100 | $26.34 | $3K | Direct | Dec 5, 2023 (1d) |
| Sep 5, 2023 | GH | ↓ Sell10b5-1 | 100 | $35.01 | $4K | Direct | Sep 6, 2023 (1d) |
| Jun 15, 2023 | GH | ↓ Sell10b5-1 | 2,766 | $37.55 | $104K | Direct | Jun 16, 2023 (1d) |
| Mar 2, 2022 | OSCR | ↓ Sell10b5-1 | 2,540 | $6.91 | $18K | Direct | Mar 3, 2022 (1d) |
| Dec 2, 2021 | OSCR | ↓ Sell10b5-1 | 3,090 | $8.75 | $27K | Direct | Dec 3, 2021 (1d) |
| Sep 1, 2021 | OSCR | ↓ Sell10b5-1 | 24,014 | $17.17 | $412K | Direct | Sep 2, 2021 (1d) |
| Mar 5, 2021 | OSCR | ↓ Sell | 95,394 | $39.00 | $3.7M | Direct | Mar 5, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GH insiders
Open-market trades in the last 12 months
About Meghan V. Joyce's insider trades
Meghan V. Joyce is a director at Guardant Health (GH). Since Mar 5, 2021, Meghan has reported no open-market purchases and 16 sales worth $5.8M on SEC Form 4. In the last 12 months: 1 sale ($1.3M).
8 sales (10% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (45 filings), grants and awards (16 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.